EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 3.0

Antifibrotic Strategies Targeting Phosphodiesterase-4 in Idiopathic Pulmonary Fibrosis: Molecular Mechanisms and Clinical Translation

Quan Ma, Shixin Zhou, Xiaodong Zhi, Caifeng Luo, Zhongbo Zhu, Xuhui Zhang, Xiping Liu iD

Clinical Pharmacology: Advances and Applications · 2026-02 · Volume 18 · 1-18

DOI: 10.2147/cpaa.s570975 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Clinical Pharmacology: Advances and Applications, 2026-02. Verfasst von Quan Ma und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of Basic Medical Sciences, Gansu University of Traditional Chinese Medicine, Lanzhou, 730000, People's Republic of China. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 77 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

idiopathic pulmonary fibrosisnerandomilastphosphodiesterasephosphodiesterase 4 inhibitor

Autor:innen und Institutionen

  • School of Basic Medical Sciences, Gansu University of Traditional Chinese Medicine, Lanzhou, 730000, People's Republic of China.
  • Department of Lung Diseases, Affiliated Hospital of Gansu University of Traditional Chinese Medicine, Lanzhou, 730000, People's Republic of China.
  • College of Integrative Medicine, Gansu University of Traditional Chinese Medicine, Lanzhou, 730000, People's Republic of China.
  • Gaolan Branch Hospital, Affiliated Hospital of Gansu University of Traditional Chinese Medicine, Lanzhou, 730200, People's Republic of China.
  • The Third Affiliated Hospital of Gansu University of Traditional Chinese Medicine (The First People's Hospital of Bai Yin City), Bai Yin, 730900, People's Republic of China.

ORCID-Profile: Xiping Liu

Zitieren

APA

Ma, Q., Zhou, S., Zhi, X., Luo, C., Zhu, Z., Zhang, X., & Liu, X. (2026). Antifibrotic Strategies Targeting Phosphodiesterase-4 in Idiopathic Pulmonary Fibrosis: Molecular Mechanisms and Clinical Translation. Clinical Pharmacology: Advances and Applications, Volume 18, 1-18. https://doi.org/10.2147/cpaa.s570975

Vancouver

Ma Q, Zhou S, Zhi X, Luo C, Zhu Z, Zhang X, et al. Antifibrotic Strategies Targeting Phosphodiesterase-4 in Idiopathic Pulmonary Fibrosis: Molecular Mechanisms and Clinical Translation. Clinical Pharmacology: Advances and Applications. 2026;Volume 18:1-18. doi:10.2147/cpaa.s570975

BibTeX
@article{Ma2026,
  author = {Ma, Quan and Zhou, Shixin and Zhi, Xiaodong and Luo, Caifeng and Zhu, Zhongbo and Zhang, Xuhui and Liu, Xiping},
  title = {Antifibrotic Strategies Targeting Phosphodiesterase-4 in Idiopathic Pulmonary Fibrosis: Molecular Mechanisms and Clinical Translation},
  journal = {Clinical Pharmacology: Advances and Applications},
  year = {2026},
  volume = {Volume 18},
  pages = {1--18},
  doi = {10.2147/cpaa.s570975}
}
Kostenlos starten →